Results 81 to 90 of about 288,633 (118)

Stability of c-Myc Protein in Early S Phase Is Regulated by the Interaction with PCNA. [PDF]

Int J Mol Sci
Cardano M, Cazzalini O, Maraventano G, Stivala LA, Zannini L, Prosperi E.   +5 more
europepmc   +1 more source

Carrier-free nanomodulators reprogramming acetate metabolism for cancer photo-immunotherapy via c-Myc inhibition-induced closed-loop regulatory circuit. [PDF]

Mater Today Bio
Zhu J, Dong D, Xu J, Tang X, Gao Y, Zhu J, Zhuang Y, Zhang P, Lv Z, Chen X, Zou J, Shi H.   +11 more
europepmc   +1 more source

Toosendanin suppresses acute myeloid leukemia by targeting DDX5/c-Myc axis to inhibit protein synthesis. [PDF]

J Transl Med
He X, Chen Z, Luo J, Chen H, Hou Y, Liu D, Liu Y.   +6 more
europepmc   +1 more source

KDM8/c-Myc axis-mediated glucose metabolism reprogramming promotes the progression of ovarian cancer. [PDF]

Sci Rep
Liu C, Xu Q, Li Z, Yang X, Mao B, Guo L, Liu X, Liu W.   +7 more
europepmc   +1 more source

A positive feedback loop between TKT and c-Myc drives TACE resistance in hepatocellular carcinoma. [PDF]

Cell Death Discov
Xiao Y, Liu M, Zhou Y, Bao Y, Zhang G, Xu B, Zheng W, Zhao H.   +7 more
europepmc   +1 more source

An antibody-PROTAC conjugate targets BRD4/c-Myc/PD-L1 to enhance immunotherapy efficacy in triple-negative breast cancer. [PDF]

Cell Rep Med
Gu Y, Li C, Zhao Y, Xu T, Zhu Y, Wang D, Wang X, Chen J, Li J, Guan X.   +9 more
europepmc   +1 more source

Inhibition of RBM23 induces ferroptosis in colon cancer cells via c-Myc regulation. [PDF]

Cancer Cell Int
Oh JJ, Lee YJ, Han YJ, Park J, Kim W, Lee IS, Lee S, Jo MG, Jung JH.   +8 more
europepmc   +1 more source

Switching of the c-Myc protein degradation pathway depending on the PP2A-B55α complex levels. [PDF]

Proc Natl Acad Sci U S A
Ando S, Ikeda S, Tanaka K, Tomabechi Y, Yamagata A, Shirouzu M, Tsunedomi R, Nagano H, Tsuji S, Sato K, Ohama T.   +10 more
europepmc   +1 more source

miRNA‑29a inhibits the proliferation of HUVECs by regulating the ITGB1/β‑catenin/c‑Myc pathway. [PDF]

Mol Med Rep
Sun Q, Chen W, Zhang S, Zhong X, Wu Y, Qian Y, Zhu L, Zhang T, Li W.   +8 more
europepmc   +1 more source

Activation of c-Myc confers resistance to venetoclax via inhibition of Bim in t(8;21)-positive acute myeloid leukemia. [PDF]

Cell Commun Signal
Yin Z, Yao Z, Chen D, Xu D, Xuan L, Liu Q, Ping B, Yu G.   +7 more
europepmc   +1 more source